Improved Adherence with Once-daily Versus Twice-daily Dosing of Mometasone Furoate Administered Via a Dry Powder Inhaler: a Randomized Open-label Study

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2010 Jan 7

PMID 20051135

Citations 45

Authors

David Price

Anne Robertson

Kevin Bullen

Cynthia Rand

Rob Horne

Heribert Staudinger

Affiliations

Soon will be listed here.

Abstract

Background: Poor adherence with prescribed asthma medication is a major barrier to positive treatment outcomes. This study was designed to determine the effect of a once-daily administration of mometasone furoate administered via a dry powder inhaler (MF-DPI) on treatment adherence compared with a twice-daily administration.

Methods: This was a 12-week open-label study designed to mimic an actual clinical setting in patients >or=12 years old with mild-to-moderate persistent asthma. Patients were randomized to receive MF-DPI 400 microg once-daily in the evening or MF-DPI 200 microg twice-daily. Adherence was assessed primarily using the number of actual administered doses reported from the device counter divided by the number of scheduled doses. Self-reports were also used to determine adherence. Health-related quality of life, healthcare resource utilization, and days missed from work or school were also reported.

Results: 1233 patients were randomized. The mean adherence rates, as measured by the automatic dose counter, were significantly better (P < 0.001) with MF-DPI 400 microg once-daily in the evening (93.3%) than with MF-DPI 200 microg twice-daily (89.5%). Mean adherence rates based on self-reports were also significantly better (P < 0.001) with MF-DPI 400 microg QD PM (97.2%) than with MF-DPI 200 microg twice-daily (95.3%). Adherence rates were lower in adolescents (12-17 years old). Health-related quality of life improved by 20% in patients using MF-DPI once-daily in the evening and by 14% in patients using MF-DPI twice-daily. Very few (<8%) patients missed work/school.

Conclusion: Mean adherence rates were greater with a once-daily dosing regimen of MF-DPI than with a twice-daily dosing regimen.This trial was completed prior to the ISMJE requirements for trial registration.

Citing Articles

The effect of the APOE4 genotype on physiological and cognitive health in randomised controlled trials with an exercise intervention: a systematic review and meta-analysis.

Spencer F, Elsworthy R, Breen L, Bishop J, Dunleavy C, Aldred S Trials. 2025; 26(1):20.

PMID: 39828710 PMC: 11744846. DOI: 10.1186/s13063-024-08696-4.

Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLE.

Hafez G, Aarnio E, Mucherino S, Kamusheva M, Qvarnstrom M, Potocnjak I J Gen Intern Med. 2024; 39(15):2917-2926.

PMID: 38941058 PMC: 11576669. DOI: 10.1007/s11606-024-08851-2.

GEMA 5.3. Spanish Guideline on the Management of Asthma.

Plaza Moral V, Alobid I, Alvarez Rodriguez C, Blanco Aparicio M, Ferreira J, Garcia G Open Respir Arch. 2023; 5(4):100277.

PMID: 37886027 PMC: 10598226. DOI: 10.1016/j.opresp.2023.100277.

Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study.

Sekerel B, Nell H, Laki I, Pak T, Contreras E, Kolarz A Clin Drug Investig. 2023; 43(9):719-728.

PMID: 37682405 PMC: 10514176. DOI: 10.1007/s40261-023-01300-8.

[Comparison of adherence as assessed by the Test of Adherence to Inhalers and Pharmacy Refill Records, in Asthma Patients. REFARMA study].

Santibanez M, Rodriguez I, Lopez-Caro J, Rodriguez-Porres M, Astruga M, Arenal S Open Respir Arch. 2023; 5(2):100238.

PMID: 37496877 PMC: 10369611. DOI: 10.1016/j.opresp.2023.100238.

References

Bender B, Milgrom H, Rand C . Nonadherence in asthmatic patients: is there a solution to the problem?. Ann Allergy Asthma Immunol. 1997; 79(3):177-85; quiz 185-6. DOI: 10.1016/S1081-1206(10)63001-3. View

Pauwels R, Pedersen S, Busse W, Tan W, Chen Y, Ohlsson S . Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003; 361(9363):1071-6. DOI: 10.1016/S0140-6736(03)12891-7. View

Onyirimba F, Apter A, Reisine S, Litt M, McCusker C, Connors M . Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol. 2003; 90(4):411-5. DOI: 10.1016/S1081-1206(10)61825-X. View

Guest J, Davie A, Ruiz F, Greener M . Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J. 2006; 14(2):88-98. PMC: 6743555. DOI: 10.1016/j.pcrj.2005.01.002. View

Storms W . Clinical trials: are these your patients?. J Allergy Clin Immunol. 2003; 112(5 Suppl):S107-11. DOI: 10.1016/j.jaci.2003.09.019. View

Rand C, Bilderback A, Schiller K, Edelman J, Hustad C, Zeiger R . Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol. 2007; 119(4):916-23. DOI: 10.1016/j.jaci.2006.12.664. View

Nayak A, Banov C, Corren J, Feinstein B, Floreani A, Friedman B . Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. Ann Allergy Asthma Immunol. 2000; 84(4):417-24. DOI: 10.1016/S1081-1206(10)62275-2. View

Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K . Can asthma control be improved by understanding the patient's perspective?. BMC Pulm Med. 2007; 7:8. PMC: 1894634. DOI: 10.1186/1471-2466-7-8. View

Bender B, Rand C . Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004; 4(3):191-5. DOI: 10.1097/00130832-200406000-00009. View

10.

Bender B, Milgrom H, Apter A . Adherence intervention research: what have we learned and what do we do next?. J Allergy Clin Immunol. 2003; 112(3):489-94. DOI: 10.1016/s0091-6749(03)01718-4. View

11.

Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B . Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343(5):332-6. DOI: 10.1056/NEJM200008033430504. View

12.

Osterberg L, Blaschke T . Adherence to medication. N Engl J Med. 2005; 353(5):487-97. DOI: 10.1056/NEJMra050100. View

13.

Nathan R, Nayak A, Graft D, Lawrence M, Picone F, Ahmed T . Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Ann Allergy Asthma Immunol. 2001; 86(2):203-10. DOI: 10.1016/S1081-1206(10)62692-0. View

14.

Kemp J, Berkowitz R, Miller S, Murray J, Nolop K, Harrison J . Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. J Allergy Clin Immunol. 2000; 106(3):485-92. DOI: 10.1067/mai.2000.109431. View

15.

Noonan M, Karpel J, Bensch G, Ramsdell J, Webb D, Nolop K . Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Ann Allergy Asthma Immunol. 2001; 86(1):36-43. DOI: 10.1016/S1081-1206(10)62353-8. View

16.

Bensch G, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B . Once-daily evening administration of mometasone furoate in asthma treatment initiation. Ann Allergy Asthma Immunol. 2006; 96(4):533-40. DOI: 10.1016/S1081-1206(10)63547-8. View

17.

Claxton A, Cramer J, Pierce C . A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23(8):1296-310. DOI: 10.1016/s0149-2918(01)80109-0. View

18.

Bayliss M, Espindle D, Buchner D, Blaiss M, Ware J . A new tool for monitoring asthma outcomes: the ITG Asthma Short Form. Qual Life Res. 2000; 9(4):451-66. DOI: 10.1023/a:1008939328060. View

19.

Jonasson G, Carlsen K, Mowinckel P . Asthma drug adherence in a long term clinical trial. Arch Dis Child. 2000; 83(4):330-3. PMC: 1718500. DOI: 10.1136/adc.83.4.330. View

20.

Iskedjian M, Einarson T, MacKeigan L, Shear N, Addis A, Mittmann N . Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002; 24(2):302-16. DOI: 10.1016/s0149-2918(02)85026-3. View